Hina Porcelli - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Hina Porcelli's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Hina Porcelli
Verified
Director, Editorial Strategy, Corporate Communications, Bristol Myers Squibb Newsroom
Beats
American Religion , Us Politics , Local Campaign Finance , State Politics
Judiciary and courts
Content
By Hina Porcelli| CONQUER Verified Dear Valued Contributors,On behalf of the entire Conquer team, I want to express our heartfelt gratitude for your unwavering support and contributions throughout 2024. Whether you have shared your story as a patient, caregiver, or healthcare professional, your contributions have fostered connections and provided comfort to those who needed it most. You have helped create a community built on understanding, empathy, and resilience that reaches far beyond our journal.
By Hina Porcelli| HMP Global Learning Network@ Data presented at the 2022 ASCO Annual Meeting by Sharon M. Castellino, MD, MSc, Emory University and Children's Healthcare of Atlanta, GA, demonstrated the superior efficacy of brentuximab vedotin plus doxorubicin, vincristine, etoposide, prednisone and cyclophosphamide (AVE-PC) to that of AVE-PC with bleomycin (ABVE-PC) for pediatric patients with previously untreated, high-risk Hodgkin lymphoma (HL).
By Hina Porcelli| CONQUER Verified Dear Valued Contributors,On behalf of the entire Conquer team, I want to express our heartfelt gratitude for your unwavering support and contributions throughout 2024. Whether you have shared your story as a patient, caregiver, or healthcare professional, your contributions have fostered connections and provided comfort to those who needed it most. You have helped create a community built on understanding, empathy, and resilience that reaches far beyond our journal.
Company Info
Bristol Myers Squibb Newsroom